Haemodynamics and Function of the Atria in Congenital Heart Disease by Cardiovascular Magnetic Resonance
1 other identifier
observational
22
1 country
1
Brief Summary
The purpose of this study is to determine whether patients with repaired congenital heart disease show differences in size or function of their heart atria compared to normal controls and depending on the nature of their heart disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jun 2009
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 16, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 24, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
November 24, 2009
CompletedFirst Submitted
Initial submission to the registry
June 10, 2014
CompletedFirst Posted
Study publicly available on registry
June 11, 2014
CompletedMarch 20, 2025
March 1, 2025
5 months
June 10, 2014
March 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Right and left atrial volume
Measurement of maximal volume (at end of systole), volume before atrial contraction (in late diastole), and minimal volume (at end of diastole) of both atria.
Day of CMR (baseline only, no intervention)
Secondary Outcomes (1)
Blood flow across the atrio-ventricular valves
Day of CMR (baseline only, no intervention)
Study Arms (2)
Tetralogy of Fallot
Patients after repair of tetralogy of Fallot
Normal
Normal controls
Eligibility Criteria
Participants for the study will be recruited among patients, children and adults, with CHD (groups 1-4) undergoing cardiac magnetic resonance examination for clinical reasons. 1. Patients after repair of coarctation of the aorta 2. Patients after repair of tetralogy of Fallot 3. Patients with transposition of the great arteries after atrial switch (Senning procedure) 4. Patients with transposition of the great arteries after arterial switch operation 5. Children without cardiovascular anomalies undergoing CMR for other clinical reasons not influencing cardiac function (control group)
You may qualify if:
- Ability to perform repetitive breath holds of 10-15 seconds each
- Written informed consent of the patients or their legal guardians
You may not qualify if:
- Patients requiring general anaesthesia
- Residual cardiac findings which might potentially influence the size and function of the atria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Children's Hospital Zürich, Switzerland
Zurich, Canton of Zurich, 8032, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Emanuela R Valsangiacomo Buechel, Prof.
University Children's Hospital Zürich, Switzerland
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 10, 2014
First Posted
June 11, 2014
Study Start
June 16, 2009
Primary Completion
November 24, 2009
Study Completion
November 24, 2009
Last Updated
March 20, 2025
Record last verified: 2025-03